Key features and details
- Rabbit polyclonal to TNNI1
- Suitable for: IHC-P
- Reacts with: Human
- Isotype: IgG
Product nameAnti-TNNI1 antibody
See all TNNI1 primary antibodies
DescriptionRabbit polyclonal to TNNI1
Tested applicationsSuitable for: IHC-Pmore details
Species reactivityReacts with: Human
Predicted to work with: Mouse, Rat
A peptide from near the N terminal residues of human TNNI1 protein (NM_003281).
FormLyophilized:Reconstitute in 200 µl sterile H2O.
Storage instructionsShipped at 4°C. After reconstitution store at -20ºC. Avoid freeze / thaw cycles.
Storage bufferPreservative: 0.02% Sodium azide
Constituent: 2% BSA
Concentration information loading...
PurityImmunogen affinity purified
Purification notesPurified by peptide affinity column.
Our Abpromise guarantee covers the use of ab85087 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Peptide ELISA titer, 1:1,000-1:10,000.
IHC-P: 1/100 - 1/500.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.
FunctionTroponin I is the inhibitory subunit of troponin, the thin filament regulatory complex which confers calcium-sensitivity to striated muscle actomyosin ATPase activity.
Tissue specificityHighest levels observed in human skeletal muscle (e.g. gastrocnemious muscle), differentiated cultures of primary human muscle cells and rhabdomyosarcoma cells cultured in low serum medium. Expressed in C2 muscle cell myoblasts and myotubes.
Sequence similaritiesBelongs to the troponin I family.
- Information by UniProt
- 2700018B22Rik antibody
- AI747285 antibody
- DKFZp451O223 antibody
ab85087 has been referenced in 2 publications.
- Li XF et al. Downregulation of the long noncoding RNA MBNL1-AS1 protects sevoflurane-pretreated mice against ischemia-reperfusion injury by targeting KCNMA1. Exp Mol Med 50:115 (2018). PubMed: 30185781
- Grajales L et al. Induction of cardiac myogenic lineage development differs between mesenchymal and satellite cells and is accelerated by bone morphogenetic protein-4. J Mol Cell Cardiol 53:382-91 (2012). ICC/IF ; Human . PubMed: 22709559